Topic Hub
6 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 6 of 6 clinical reviews.
Complete clinical guide to the Addyi (flibanserin) alcohol interaction: hypotension risk, the REMS program, study data, dosing rules, and practical patient instructions reviewed by the HealthRX medical team.
Read clinical reviewFlibanserin (Addyi) causes clinically significant CNS depression and hypotension that interact dangerously with anesthetic agents. Learn the evidence-based perioperative management protocol, required washout periods, and alcohol interaction risks.
Read clinical reviewA clinical deep-dive into the flibanserin (Addyi) and caffeine interaction, covering pharmacokinetics, CNS depression risk, alcohol warnings, and safe dosing guidance reviewed by the HealthRX medical team.
Read clinical reviewA clinical deep-dive into the flibanserin-cannabis interaction, covering CNS depression risks, CYP3A4 inhibition, hypotension, and what the FDA label and primary literature say about concurrent use.
Read clinical reviewA full clinical breakdown of the flibanserin, nicotine interaction, covering pharmacokinetics, CNS depression risk, label warnings, and what smokers and vapers should discuss with their prescriber.
Read clinical reviewA clinician-reviewed guide to the Addyi (flibanserin) vaccine interaction profile, covering CNS depression risks, alcohol warnings, CYP3A4-based drug interactions, and how routine immunization fits safely into treatment.
Read clinical review